1. Home
  2. TK vs LBRX Comparison

TK vs LBRX Comparison

Compare TK & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$10.64

Market Cap

942.3M

ML Signal

HOLD

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

HOLD

Current Price

$31.42

Market Cap

958.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
LBRX
Founded
1973
2015
Country
Bermuda
United States
Employees
N/A
27
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
942.3M
958.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TK
LBRX
Price
$10.64
$31.42
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$46.60
AVG Volume (30 Days)
553.1K
351.9K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
15.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.12
$13.40
52 Week High
$14.38
$35.35

Technical Indicators

Market Signals
Indicator
TK
LBRX
Relative Strength Index (RSI) 41.57 49.89
Support Level $9.63 $26.75
Resistance Level $12.50 $34.10
Average True Range (ATR) 0.39 1.98
MACD 0.07 -0.30
Stochastic Oscillator 58.74 34.42

Price Performance

Historical Comparison
TK
LBRX

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Share on Social Networks: